Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Interest-Expense" stands at 60.34 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025.
Hansoh Pharmaceutical Group Co Ltd's second quarter result of 0.3821 Billion HKD for the item "Interest Expense" represents a decrease of -98.66 percent compared to it's first quarter result.
Also, Hansoh Pharmaceutical Group Co Ltd's second quarter result of 0.3821 Billion HKD for the item "Interest Expense" represents a decrease of -22.16 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Hansoh Pharmaceutical Group Co Ltd's second quarter result of 60.34 Billion HKD for the item "Interest Expense" represents a decrease of -0.18 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.45 percent compared to the value the year prior.
The 1 year change in percent is 12.45.
The 3 year change in percent is 16,192.37.
The 5 year change in percent is 24,234.31.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Expense | 280,205,508,085.11 |